When exploring the world of biochemical research, the angiotensin I peptide sequence stands out as a fundamental subject of study. As someone who frequently reviews peptide literature and documentation, I have found that understanding the structural composition of these chains is essential for anyone interested in the precision of laboratory research and peptide synthesis.
The Structural Identity of Angiotensin I
At its core, Angiotensin I is a ten amino acid peptide that serves as Ile(5)-angiotensin II (1-7) is an angiotensin compound consisting of the linear heptapeptide sequenceL-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro. It has a role Read more a vital precursor in various biochemical pathways. Its primary structure is defined by the sequence DRVYIHPFHL, which corresponds to the three-letter code Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu.
From a technical perspective, this decapeptide is often represented as H-DRVYIHPFHL-OH. When sourcing this material for analytical purposes, researchers often look for a molecular weight of approximately 1296.48 g/mol and a high purity level, typically >95%. You may also encounter it referred to as the KD20 peptide, sequence: H-DRVYIHPFHL-OH, which is a common designation in specialized catalogs.
Amino acid sequence:Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile "This conversion reduces the peptide from ten amino acids (angiotensin I) to Read moreVariations and Related Sequences
The study of peptide sequences is not limited to the full ten-amino-acid chain. My review of the available data reveals several important variations that are frequently categorized under the broad umbrella of angiotensin:
* Angiotensin (1-9): Formed when enzymes act upon the primary chain, this nine-amino-acid variant (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His) appears in studies involving ACE2 hydrolysis. It is often cited with the sequence DRVYIHPFH-OH.
* Angiotensin I/II (1-6): This shorter chain, consisting of Asp-Arg-Val-Tyr-Ile-His, is often studied for its role in specific biochemical modeling.
* Angiotensin-(1-7): This heptapeptide, defined by the sequence L-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro, represents a distinct structural configuration often discussed in the context of receptor interaction.
Insights into Synthesis and Purity
When handling these compounds, the amino acid sequence is the defining characteristic that dictates the molecule's behavior in an experimental setting. Whether you are looking at the standard SEQUENCE: H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH or investigating truncated versions, the purity (often veri by Z He·2021·Cited by 35—Peptides inhibitingAngiotensin-I converting enzyme (ACE, EC. 3.4.15.1) are possible cures of hypertension. Food-derived ACE-inhibitory peptides are popular fied by HPLC) and the counter-ion (frequently TFA salts) are critical parameters Its primary sequence isAsp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu. The conversion of Angiotensin I to the active octapeptide Angiotensin II is a critical Read more .
In my experience, comparing different sequences requires attention to detail. For instance, while the standard human form is well-documented, some research involves homologous comparisons, such as homologous in 5 residues with other mammalian enzymes, which highlights the evolutionary conservation of these peptide structures.
Amino acid sequence:Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile "This conversion reduces the peptide from ten amino acids (angiotensin I) to Read moreWhy Sequence Precision Matters
The DRVYIHPFHLACE relationship is a cornerstone of this field. Because this specific decapeptide is the direct substrate for conversion enzymes, even minor modifications to the Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu chain can significantly alter how the molecule is processed.
For those conducting experiments, knowing that the peptide is involved in the modulation of vascular tone and electrolyte homeostasis provides context for why researchers are so focused on the Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His segment. Whether you are analyzing Tyr-Leu-Tyr-Glu-Ile-Ala or other related fragments, the ability to confirm the Novel Angiotensin-I Converting Enzyme Inhibitory Peptides exact sequence is the first step toward reproducible results.
Ultimately, wh AngiotensinI is produced by the action of renin (an enzyme produced by the kidneys) on a protein called angiotensinogen, which is formed by the liver.Read more ether you are referencing the H-DRVYI HPFHL-OH notation or the full Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile precursor, maintaining a high standard for documentation and purity is essential for any professional working with these complex biological tools.